Title
Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor).
Document Type
Article
Publication Date
12-26-2022
Publication Title
Clinical lung cancer
Volume
S1525-7304
Issue
22
First Page
00298-4
Recommended Citation
Ghimire B, Pokharel A, Karki U, Thapa S, Chisti MM. Anaplastic lymphoma kinase (ALK) positive neuroendocrine tumor of lung with favorable response to alectinib (ALK Inhibitor). Clin Lung Cancer. 2022 Dec 26:S1525-7304(22)00298-4. doi: 10.1016/j.cllc.2022.12.004. Epub ahead of print. PMID: 36690569.
DOI
10.1016/j.cllc.2022.12.004
ISSN
1938-0690
PubMed ID
36690569
COinS